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Protein carbamylation by cyanate is a post-translationalmod-
ification associated with several (patho)physiological condi-
tions, including cardiovascular disorders. However, the bio-
chemical pathways leading to protein carbamylation are
incompletely characterized. This work demonstrates that the
hemeproteinmyeloperoxidase (MPO), which is secreted at high
concentrations at inflammatory sites from stimulated neutro-
phils and monocytes, is able to catalyze the two-electron oxida-
tion of cyanide to cyanate and promote the carbamylation of
taurine, lysine, and low-density lipoproteins. We probed the
role of cyanide as both electron donor and low-spin ligand by
pre-steady-state and steady-state kinetic analyses and analyzed
reaction products by MS. Moreover, we present two further
pathways of carbamylation that involve reaction products of
MPO, namely oxidation of cyanide by hypochlorous acid and
reaction of thiocyanate with chloramines. Finally, using an in
vivo approach with mice on a high-fat diet and carrying the
human MPO gene, we found that during chronic exposure
to cyanide, mimicking exposure to pollution and smoking,
MPO promotes protein-bound accumulation of carbamyllysine
(homocitrulline) in atheroma plaque, demonstrating a link
between cyanide exposure and atheroma. In summary, our find-
ings indicate that cyanide is a substrate forMPO and suggest an
additional pathway for in vivo cyanate formation and protein
carbamylation that involves MPO either directly or via its reac-
tion products hypochlorous acid or chloramines. They also sug-
gest that chronic cyanide exposure could promote the accumu-
lation of carbamylated proteins in atherosclerotic plaques.
Carbamylation is a post-translationalmodification of biolog-
ical molecules bearing an amino group. It occurs in several
physio- and/or pathophysiological conditions. For example, it
is well known that the -amino group of lysine residues of pro-
teins can be converted to carbamyllysine (1–4), also named
homocitrulline (Hcit),6 and that chronic renal insufficiency
correlates with enhanced carbamylation mediated by urea-de-
rived cyanate (O–C'N). In patients with renal disease, car-
bamylation of low-density lipoproteins (LDLs) is considered as
a nontraditional risk factor for cardiovascular insufficiency. It
manifests all of the biological effects relevant to atherosclerosis,
including endothelial cell injuries, expression of adhesion mol-
ecules, and vascular smooth muscle cell proliferation (5). Car-
bamylation of type I collagen has been shown to induce confor-
mational changes and reduce its ability to activate human
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SJ/AL/BRIC/130. This study was also supported in part by National Insti-
tutes of Health Grants RO1-NS074303 (to W. F. R.) and R43 AG040935 (to
R. A. M.). This work was also supported by the Institute of Pathology and
Genetics (IRSPG, Loverval, Belgium) and the “CHU of Charleroi.” Additional
funds to support this work were provided by Sanford Burnham Prebys
MedicalDiscovery Institute. Theauthorsdeclare that theyhavenoconflicts
of interestwith the contents of this article. The content is solely the respon-
sibility of the authors and does not necessarily represent the official views
of the National Institutes of Health.
This article contains Figs. S1–S5.
1 These authors contributed equally to this work.
2 Postdoctoral researcher supported by the Belgian Fund for Scientific
Research (FRS-FNRS).
3 Research Fellow of FRS-FNRS.
4 Research Director of FRS-FNRS.
5 To whom correspondence should be addressed: Laboratory of Pharmaceu-
tical Chemistry and Analytical Platform, Faculty of Pharmacy, Université
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polymorphonuclear neutrophils involved in the immune
response (6).
Recently,myeloperoxidase (MPO) has been demonstrated to
be indirectly involved in protein carbamylation (7). This
enzyme, a member of the peroxidase-cyclooxygenase super-
family (8), is secreted at inflammatory sites from stimulated
neutrophils and also from monocytes (9). It catalyzes the two-
electron oxidation of thiocyanate (S–C'N), thereby produc-
ing hypothiocyanous acid (HO–S–C'N) and cyanate as a
minor by-product (7). Protein carbamylation may therefore be
driven not only by uremia but also by inflammation. Upon
exposure of LDL to eitherMPO/H2O2/SCN or the potassium
salt of O–C'N, protein recognition by LDL receptor was
attenuated, whereas its interaction with the scavenger receptor
SR-A1 was enhanced. A clear relationship between the plasma
levels of protein-bound -carbamyllysine (Hcit) and an in-
creased risk of cardiovascular disease could be established (7).
We hereafter demonstrate the existence of a new alternative
mechanism for cyanate formation and potential protein car-
bamylation at sites of inflammation, according to the following
reaction, which involves the hydrogen peroxide–mediated oxi-





Cyanide is well known as a product of organic material com-
bustion (10) (atmospheric pollution, tobacco smoking) or from
intake of cyanogenic glycosides (almond) (11). In vivo, it is a
universal ligand able to bind to and inhibit heme enzymes.
Exposure to high concentrations results in death within sec-
onds to minutes by impairment of dioxygen (O2) distribution
within the body and inhibition of the respiratory electron trans-
port chain in the mitochondria (12). Five-coordinated ferric
high-spin heme proteins (e.g. cytochrome c oxidase, methemo-
globin, metmyoglobin, catalase, peroxidases, etc.) are its pref-
erential targets. Cyanide, which at most biological pH levels is
protonated (pKa 9.14), binds as an anion to Fe(III) and trans-
forms the corresponding heme protein into its six-coordinated
low-spin (LS) form, thereby impeding the interaction with nat-
ural substrates (e.g. O2 or H2O2). The binding rates and com-
plex equilibria involved are very variable. Typically, eukaryotic
peroxidases (including MPO) and catalases bind cyanide rap-
idly (1.1 105 M1 s1 to 1.3 106 M1 s1) (13–17), taking up
both the anion and a proton (18). So far, this LS complex for-
mation has been thought to effectively block the redox chemis-
try of all heme enzymes without any exceptions (KD  1–10
M). However, the present study unequivocally demonstrates
that cyanide can act both as ligand of MPO and electron donor
to compound I of MPO.
Myeloperoxidase is a unique oxidoreductase in human phys-
iology. The reconstructed phylogeny of mammalian peroxi-
dases indeed demonstrates that MPOs form a well-separated
clade within the vertebrate peroxidases (i.e. Family 1 of the per-
oxidase-cyclooxygenase superfamily) (8). This superfamily also
includes peroxidasins, peroxinectins, cyclooxygenases, and
dual oxidases (8). Fig. 1A depicts the family of vertebrate per-
oxidases, with the clades of myeloperoxidases and eosinophil
peroxidases (EPOs) being well separated from the other
branches. Segregation of MPO is well reflected by its unique
biophysical and biochemical properties (19) that are closely
related to its physiological role and the nature of its substrates.
It participates in innate immune defense mechanisms through
formation of microbicidal-reactive oxidants and diffusible rad-
ical species. Its unique substrate is chloride that is oxidized to
antimicrobial hypochlorous acid (HOCl). Chloride oxidation is
a thermodynamically challenging reaction that requires the for-
mation of strong oxidizing redox intermediates (i.e. the
so-called “compound I” formed by oxidation of ferric MPO by
hydrogen peroxide) (Fig. 2A) (20). The standard reduction
potential of the couple compound I/MPO(III) (E°  1.16 V)
provides the driving force of this reaction (Fig. 2A). Moreover,
as will be demonstrated below, it also uniquely enablesMPO to
oxidize cyanide to cyanate, thereby contributing to a so far
unknown route for protein carbamylation. The presented data
also suggest multiple pathways of cyanate formation and pro-
tein carbamylation that involveMPO either directly or its reac-
tion products hypochlorous acid and/or chloramine. Experi-
ments in mouse model demonstrate the relevance of these
pathways in vivo as cyanide is directly metabolized and pro-
motes accumulation of protein-bound Hcit in atheroma
plaque.
Results
Hydrogen peroxide consumption mediated by cyanide
In a preliminary study, the consumption of hydrogen perox-
ide byMPO, promoted by cyanide, was probed by amperomet-
ric monitoring. Fig. 1B clearly shows that 0.5 M MPO con-
sumes 100 M H2O2 within 300 s in the presence of 100 M
cyanide, whereas no effect is observed under identical condi-
tions with related enzymes, such as lactoperoxidase (LPO) and
EPO. At lower cyanide concentrations (50–100M),MPO rap-
idly consumes H2O2, whereas the inhibitory effect is evident at
higher concentrations (500–1000 M; Fig. 1B). The slow H2O2
consumption observed in control experiments (absence of cya-
nide) is due to the well-known low (pseudo)catalase activity of
mammalian peroxidases (20).
Cyanide acts as electron donor for MPO compound I
Myeloperoxidase catalyzes one- and two-electron oxidation
reactions (Fig. 2A). The relevant redox intermediate involved in
both reactions (compound I; i.e. an oxoiron(IV) porphyrin rad-
ical cation) is formed via a two-electron oxidation of the ferric





In two-electron transitions, compound I (about 50% hypo-
chromicity of Soret band comparedwith ferricMPO) is directly
reduced to ferricMPO (Soret band at 428 nm), whereas in one-
electron transitions, compound II (Soret band at 456 nm) is
MPO oxidizes cyanide into cyanate
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formed. These reactions can easily be probed by sequential
stopped-flow spectroscopy. Fig. 1C shows a representative
series of spectra obtained by mixing 4 M MPO compound I
with 100 M cyanide. The reaction is monophasic and linearly
dependent on cyanide concentration. It rapidly forms a MPO
species that had its Soret band at 456 nm, which could derive
from either compound II or the LS complex between ferric
MPO and cyanide (19). The determined apparent bimolecular
rate constant is (5.3 0.5) 105 M1 s1 at pH 7.0 and 25 °C. It
is unlikely that cyanide mediates the reduction of compound I
to compound II, because this reaction is thermodynamically
unfavorable (see below). Moreover, the reaction of preformed
compound II with cyanide probed in the sequential stopped-
flow mode clearly demonstrated that compound II does not
participate in the turnover of the MPO/H2O2/CN system. By
contrast, the observed spectral transition suggests the cyanide-
mediated direct reduction of compound I to ferric MPO. The
latter rapidly binds excess cyanide, forming the LS complex
with Soret maximum at 456 nm (see also Figs. S4 and S5).
For comparison, the reaction of cyanide with preformed
compound I of LPO and EPO as well as horseradish peroxidase
(a model plant-type peroxidase) was also investigated under
identical conditions.With LPO and EPO, compound I is slowly
transformed to compound II (2 s1), which is a well-known
phenomenon of intramolecular electron transport in the
absence of exogenous electron donors (21–23) (see Fig. 1A).
Horseradish peroxidase compound I is stable in the presence of
cyanide (see Fig. S1B).
MPO-mediated cyanide oxidation generates cyanate
To prove direct reduction of compound I to ferric MPO and
concomitant two-electron oxidation of cyanide to OCN,
MPO was incubated with both H2O2 and the isotopomers
Figure 1. A, reconstructed phylogenetic tree showing the family of verte-
brate peroxidases, including the mammalian enzymes MPO, EPO, LPO, and
thyroid peroxidase (TPO). B, amperometric measurements (650 mV) of the
H2O2 consumption in the presence of 0.5Mperoxidases (LPO, EPO, orMPO),
100 M H2O2, and
CN at various concentrations. C, reaction of 2 M MPO
compound I with 50 M cyanide followed in the sequential-mixing stopped-
flow mode. Conditions were as follows: 100 mM phosphate buffer, pH 7.0,
25 °C. Arrows, wavelength with absorbance changes. The first spectrum was
taken 1.3 ms after mixing. Inset, typical time trace followed at 456 nm (maxi-
mum absorbance of MPO(III)-cyanide complex) and plot of the pseudo-first-
order rate constants, kobs, versus cyanide concentrations.
Figure 2. Carbamylation promoted by the system MPO/H2O2/
CN sys-
tem andMPO-typical reaction products. A, MPO-typical oxidation of chlo-
ride to hypochlorous acid (i.e. chlorination cycle). Ferric MPO (PorFe(III)) is
oxidized to compound I (PorFe(IV)O;oxoiron(IV) porphyrin radical),which
is directly reduced to the resting state by chloride, thereby releasing hypo-
chlorous acid (HOCl/OCl). Hypochlorous acidmediates the oxidation of cya-
nide to cyanate and the formation of chloramines, which may be also
involved in carbamylationbydirect reactionwith thiocyanate (NEWASPECTS).
B, two-electron oxidation of cyanide to cyanate byMPO compound I, thereby
restoring the ferric protein and releasing cyanate (5.3  105 M1 s1; NEW
ASPECTS). Ferric MPO binds cyanide, forming the low-spin complex (Por-
Fe(III)-CN, KD 3.3M). FurtherMPO-typical reactions include the one-elec-
tron reduction of compound I to compound II by H2O2 (14) or by other one-
electron donors followed by compound II reduction to ferric MPO. Kinetic
constants were calculated from current experiments (see “Experimental pro-
cedures”) or from the literature when already known (13–17).
MPO oxidizes cyanide into cyanate
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CN, [13C]CN, or [13C,15N]CN.The reaction products were
analyzed by MS. Fig. 3 shows the formation of a reaction prod-
uct with an appropriate m/z (i.e. m/z 43) and a fragment ion
at m/z  27. Fig. 4A illustrates the formation of cyanate using
the three isotopomers. Upon using CN, [13C]CN, or
[13C,15N]CN, peaks at m/z values of 41.999, 43.002, or 43.999
were found, clearly demonstrating the formation of the isoto-
pomers OCN, [13C]OCN or [13C,15N]OCN, respectively.
In the absence of cyanide or hydrogen peroxide or MPO, no
cyanate was produced except for hydrogen peroxide with cya-
nide, where a low cyanate production was detected (around
1%). Furthermore, using a calibration curve of cyanate, we were
able to calculate that around 13% of cyanide is transformed to
cyanate (n  3) after 1 h (see supporting data for detailed
results). These findings clearly indicate that the system MPO/
H2O2/cyanide is able to produce cyanate and that the conver-
sion of cyanide to cyanate is incomplete (Fig. 4A).
Carbamylation of taurine, lysine, and LDL
Furthermore, cyanate produced by MPO-mediated cyanide
oxidation was probed in its reaction with nucleophilic amino
groups in both taurine and lysine. Taurine is a low-molecular
weight amine abundant in millimolar concentration in the
cytosol of neutrophils (24). In this study, taurine was used as a
chemical model of monoamine because it is stable and its chlo-
rination is well documented. Taurine (1 mM) was incubated
with MPO (0.3 M), hydrogen peroxide (1 mM) and [12C]CN,
[13C]CN, or [13C,15N]CN (1 mM) in ammonium acetate
buffer, pH 7.4, and the reaction mixture was analyzed by elec-
trospray ionization (ESI)-quadrupole TOF (QTOF)MS in neg-
ativemode. Peaks at expectedm/z values of 167.0109, 168.0284,
and 169.0155 corresponding to 12C-, 13C-, and 13C,15N-car-
bamylated taurine were found (Fig. 4B). To further confirm the
formation of carbamylated taurine, the isolated peaks were
fragmented, leading to peaks with m/z values of 124.0074 and
79.9581, respectively, that fully matched with fragments
obtained from standard carbamylated taurine (Fig. 4C). Similar
experiments performed with lysine demonstrated the forma-
tion ofHcit (Fig. S2). In the absence of either hydrogen peroxide
or MPO, carbamylation of taurine or lysine was negligible or
diminished.
Another tested target for carbamylationwas LDL. LDLswere
incubated with the MPO/H2O2/cyanide system before being
delipidated and hydrolyzed. Subsequently, the formation of
protein-bound Hcit was analyzed by MS and correlated with
the abundance of protein-bound lysine by monitoring the ratio
Hcit/Lys. A low amount of Hcit was detected in native LDLs.
The incubation of LDLs with MPO, H2O2, and increasing con-
centrations of cyanide led to increasing Hcit/Lys ratios (1.5-
and 12-fold increases; Fig. 5A). The addition of chloride (150
mM) to the MPO/H2O2 system in the presence of 100 M cya-
nide even increased the extent of carbamylation. Similar levels
of carbamylation were observed when LDLs were incubated
with HOCl and cyanide (100 M) (Fig. 5A). In the absence of
MPO, the Hcit concentration was almost identical to that of
native LDLs (data not shown). Furthermore, a positive control
with 100 M of cyanate (OCN) was analyzed. This concentra-
Figure 3. TandemMS/MS determination of cyanate production.MS spectra show a peak around 43m/z corresponding to 13C-cyanate, whenMPO (1 M)
was added to a mixture of [13C]cyanide (2 mM) and H2O2 (200 M) (pink solid line). Results obtained upon the repeated addition of H2O2 (three times) are
depicted by the green solid line. MS/MS spectra show a peak around 27m/z corresponding to the fragmentation of [13C]cyanate into [13C]cyanide (green solid
line).
MPO oxidizes cyanide into cyanate
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tion was used supposing the full conversion of cyanide to cya-
nate. Surprisingly, this experiment showed a lower carbamyla-
tion compared with the MPO/H2O2/cyanide/chloride system
but a 3 times higher carbamylation when compared with the
MPO/H2O2/cyanide system (Fig. 5A).
The quantitative approach of Hcit formation enabled us to
observe that approximately 0.7% of thiocyanate (100M)medi-
ated the formation of Hcit in the presence of MPO and H2O2.
When cyanide was added in the same concentration as thiocy-
anate (100 M), the thiocyanate-mediated formation of Hcit
decreased to 0.35%; however, the cyanide-mediated formation
of Hcit increased to 0.7%. If the thiocyanate concentration was
increased to 400 M, the thiocyanate-mediated formation of
Hcit increased to 0.4%, whereas the cyanide-mediated forma-
tion decreased to 0.4%. These results highlight the importance
of generatedHOCl for theHcit formationmediated by cyanide.
Finally, the positive control using cyanate to carbamylate LDLs
at 100M revealed that only 0.1% of cyanate was converted into
Hcit under the conditions used.
Finally, we tested the contribution of each anion (thiocya-
nate, cyanide, and chloride) in the carbamylation process. Upon
the addition of cyanide to the systemMPO/H2O2/thiocyanate,
the contribution of thiocyanate in the carbamylation process
decreased (Fig. 5B, left). However, this was compensated by
cyanide-mediated carbamylation, as illustrated by an increase
of labeled and total Hcit content (labeled and not labeled; Fig. 5,
B (right) and C). Interestingly, when chloride (150 mM) was
added in addition to cyanide to the MPO/H2O2/thiocyanate
system, there was a drop in the formation of Hcit from thiocy-
anate (Fig. 5B, left). However, the total carbamylation content
increased (total Hcit; Fig. 5B, right) as cyanide-dependent for-
mation of Hcit (Fig. 5C) increased.
Role of hypochlorous acid and chloramines in carbamylation
pathways
Hypochlorous acid (HOCl) is an important reaction product
of MPO deriving from the two-electron oxidation of chloride
by compound I. It is well known that HOCl reacts with amines
forming chloramines (e.g. taurine chloramines) that in addition
contribute to the antimicrobial activity of MPO (25). We could
demonstrate that HOCl but not monochloramine is another
oxidant of cyanide. Upon mixing hypochlorous acid and cya-
nide with taurine, carbamylation of taurine is observed (Fig.
S3). Actually, HOCl promotes the formation of cyanate from
cyanide (Fig. S3). As demonstrated above, formation of Hcit is
observed upon incubation of LDL with HOCl and cyanide
(Fig. 5A).
Additionally, carbamylation can derive from the reaction
between thiocyanate and monochloramine. Fig. 4D shows the
formation of carbamylated adducts withm/z values of 167.0115
and 168.0160 by using 12C- or 13C-labeled thiocyanate and tau-
rine mono-chloramine. Incubating HOCl-oxidized LDL with
thiocyanate increases the Hcit/lysine ratio (Fig. 5B).
Cyanide exposure promotes protein-bound carbamylation in
atheroma plaque
To confirm that those reactions participate in formation of
carbamylated proteins in vivo, we used humanized MPO mice
transgenic for the intact human MPO gene (463G allele)
(hMPO-TG) with native promoter elements. The rationale for
using the hMPO-TG mice is that the human MPO gene is
expressed in macrophages in atherosclerotic plaques, whereas
themouseMPOgene is not expressed. This is thought to be due
in part to a primate-specific Alu element with binding sites for
SP1 and nuclear receptors, including PPAR (26). Prior studies
show MPO presence in atherosclerotic plaques in the MPOG-
LDLR/ model correlating with increased atherosclerotic
plaque and hyperlipidemia (27). This cross was used in an ear-
lier study that found increased protein-bound homocitrulline
content in atheroplaque laden aorta in huMPOG-LDLR/
mice as compared with LDL receptor–deficient LDLR/ con-
trols (7). In this experiment, control mice, human MPO trans-
genics (463G allele) (hMPO-TG) mice, and hMPO-TG
crossed to the LDLR/ mice (all on C57BL/6 background)
were treated with [13C,15N]cyanide (0.4 mg/kg everyday, 	5
g/day) or PBS as negative control for 8 weeks (see “Experi-
mental procedures”). Furthermore, mice were exposed to acute
inflammation before sacrifice using intraperitoneal injection of
zymosan as in prior studies (Wang et al. (7) with slight modifi-
cations). Protein-bound [13C,15N]Hcit was analyzed in plasma,
in atheroma plaques, and in the supernatant and cell pellets of
peritoneal lavages. Fig. 6A shows that hMPO-TG-LDLR/
mice treated with [13C,15N]cyanide have an increased ratio of
[13C,15N]Hcit/Hcit (0.011  0.003) in the atheroma plaques
compared with animals treated with PBS (ratio of 0.0009 
0.0005, p
 0.01). Labeled cyanide was used because carbamy-
lation naturally occurs in vivo. Labeling with [13C,15N]Hcit
allowed us to demonstrate that chronic exposure to cyanide
causes carbamylation via MPO activity. In this context, the
ratio of [13C,15N]Hcit/Hcit was the preferred readout to
express carbamylation. On the other hand, [13C,15N]Hcit was
too low in plasma, cell pellets, and supernatant of peritoneal
lavages and was not detected. Nevertheless, it is worth noting
that Hcit levels in atheroma plaques were the same in the cya-
nide hMPO-TG-LDLR/ mice and PBS control hMPO-TG-
LDLR/mice (Fig. 6B), showing that it is the chronic exposure
to cyanide that led to increased carbamylation byMPO-depen-
dent processes.
Figure 4. Mass spectrometric analyses. A, oxidation of cyanide by theMPO/H2O2 system. The isotopomers of
CN (final concentration 1mM) weremixed
with H2O2 (1mM) in 10mM ammonium acetate buffer, pH 7.4, and the reactionwas startedwith 0.3M human recombinantMPO at 37 °Cwith a reaction time
of 1h.OCN,O13CN, andO13C15Npeaks (at 41.9997, 43.0030, and43.9999m/z, respectively) couldbedetected,which correspond to theoxidationproducts
of cyanide isotopes. Spectra have been generated by subtracting spectra of a blank (buffer alone). B, taurine carbamylation. Taurine (1mM)wasmixedwith 0.3
M human recombinant MPO and isotopic cyanide (1 mM) for 12 h (37 °C) in 10mM ammonium acetate buffer, pH 7.4, and the reaction was started with 1mM
H2O2. A peak was detected at m/z of 167.0109, which corresponds to [
12C]carbamyltaurine and MS/MS spectra fit with those of the control. In similar
experiments with isotopomers, peaks were detected atm/z 168.0284 and 169.0155, which correspond to 13C- and 13C,15N-labeled carbamyltaurine. C, MS
and MS/MS spectra of carbamyltaurine obtained after mixing taurine (1 mM) and cyanate (1 mM) in the acetate buffer and overnight incubation. D, MS and
MS/MS spectra for the reaction of taurine chloramines (formed by mixing of 0.5 mM HOCl and 1 mM taurine) with 12C- and 13C-labeled thiocyanate after a
reaction time of 12 h. Peaks detected at m/z values 167.0115 and 168.0160 correspond to 12C- and 13C-labeled carbamyltaurine (absent in the taurine
chloramine MS spectra). Their identity was confirmed by MS/MS experiments (D, inset).
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Discussion
Mounting evidence for the involvement of MPO in athero-
genesis has emerged for the past decades. It is now accepted
that MPO catalyzes oxidation reactions via the release of reac-
tive halogenating and nitrating species that render LDL athero-
genic and high-density lipoprotein dysfunctional (28–33). In
mice, Wang et al. (7) showed a marked increase in the content
of protein-bound homocitrulline at atherosclerotic plaque-
laden aortas of human MPO-transgenic mice as compared
with nontransgenic counterparts. In both clinical and exper-
imental in vivo situations, MPO seems to be a major catalytic
component.
The enhanced consumption of hydrogen peroxide in the
presence of low cyanide concentrations and the strict concen-
tration dependence of compound I reduction unequivocally
demonstrate the role of cyanide as electron donor for MPO.
The inability of cyanide to promote the transition of compound
I into compound II fits with the high one-electron reduction
potential of the CN/CN couple (1.9 V) (20) that is signifi-
cantly higher than that of the redox couple compound I/com-
pound II (1.35 V) (34).
The observed spectral transition (Fig. 1C) can be explained
by the following reaction sequence that involves cyanide as








Reactions 3 and 4
The calculated biomolecular rate of the reaction between
cyanide andMPO(III) was determined to be 1.9 106 M1 s1
at pH 7.0 and 25 °C (k3, Reaction 4). Because k3  k2, the
measured rate constant of the transition compound I 3
MPO(III)3 LS MPO-cyanide complex reflects k2 (Fig. 2). The
two-electron oxidation of cyanide (k2) is fast (5.3 105 M1 s1
at pH 7.0 and 25 °C) and reflects the high oxidation capacity of
MPO, which is the consequence of heme distortion due to
unique heme-to-protein linkages, including an electron-with-
drawing vinyl-sulfonium group (19). It is noteworthy that
higher concentrations of cyanide favor theMPO-CN complex
formation (k3), limiting the MPO activation by reaction with
H2O2 (k1). Catalysis of the two-electron oxidation of cyanide by
MPO is unique because related human peroxidases like LPO
andEPOdid not consumehydrogen peroxide in the presence of
cyanide.
Mass spectrometric analyses have confirmed the production
of cyanate derived from the two-electron oxidation of cyanide
by compound I (see Fig. 2). This was supported by consecutive
carbamylation reactions of produced cyanate with -amino
groups of taurine and of free or LDL-bound lysine (Figs. 3–5).
However, quantitativeMS analyses also demonstrated that only
13% of cyanide was converted to cyanate by the MPO/H2O2/
cyanide system (Fig. 4A). Nevertheless, the incubation of cya-
nide with HOCl (same concentration as hydrogen peroxide; 1
mM) converted only 20% of the cyanide to cyanate. It is also
noteworthy that higher concentrations of cyanide (e.g. 1 mM)
did not increase LDL carbamylation, which corroborates the
kinetic studies (Fig. 5A).
In addition, the present work suggests further new routes of
carbamylation, namely cyanate formation by HOCl-mediated
cyanide oxidation and/or by reaction of stable chloramineswith
thiocyanate (35, 36). Both pathways follow reactions that only
indirectly depend on MPO. Chloramines are relatively stable
derivatives and are produced by the reaction of amines with
HOCl released fromMPOat sites of inflammation (37). In addi-
tion to thiocyanate oxidation (7), our findings show that MPO
can promote carbamylation in three additional ways: (i) by
direct oxidation of cyanide, (ii) by reaction of hypochlorous
Figure 5. Formation of carbamylated LDL. A, box-whisker plots (5th to 95th percentile) showing the ratios between Hcit and Lys residues (ratio Hcit/Lys),
including conditions using only cyanide as substrate. B, box-whisker plots (5th to 95th percentile) showing the ratios between Hcit and Lys residues (ratio
Hcit/Lys), including conditions using thiocyanate (SCN) and labeled cyanide ([13C,15N]CN). Left, only monoisotopic Hcit (unlabeled) is considered; right,
total Hcit is considered (Hcit  [13C,15N]Hcit). C, box-whisker plots showing the ratios between labeled homocitrulline ([13C,15N]Hcit) and Hcit (ratio
[13C,15N]Hcit/Hcit). Native LDLs were incubated overnight at 37 °C in buffer (10 mM phosphate, pH 7.4) in the presence of MPO (300 nM), H2O2 (1 mM), and/or
chloride anions (150 mM) and/or HOCl (1 mM) and/or thiocyanate (SCN, 100 or 400 M) and/or cyanide (CN) and/or [13C,15N]cyanide ([13C,15N]CN). LDLs
were then delipidated, hydrolyzed by microwave under acidic conditions. Amino acid residues were labeled and, finally, analyzed using LC-MS/MS. Each
condition was performed in quadruplicate (n 4). *, statistically significant difference with the native LDL condition (Kruskal–Wallis, p
 0.01).
Figure 6. In vivo effect of cyanide. Exposure of hMPO-TG-LDLR/mice to
[13C,15N]cyanide (0.4 mg/kg/day) led to protein-bound [13C,15N]Hcit forma-
tion in atheroma plaque. Mice were exposed for 8 weeks to isotope-labeled
cyanide (n  8) or to PBS (control, n  5). Protein-bound Lys, Hcit, and
[13C,15N]Hcitweremonitored, and [13C,15N]Hcit/Hcit (A) andHcit/Lys (B) ratios
were calculated. A statistically significant difference was observed between
groups (t test, p
 0.001).
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acid with cyanide, or (iii) by reaction of chloramines with
thiocyanate.
In vivo, several anions compete with cyanide for reaction
with MPO compound I, including chloride (150 mM) and thio-
cyanate (10–500 M). We observed that in the presence of
chloride, thiocyanate, and cyanide, carbamylation of lysine res-
idues was mediated by oxidation of both thiocyanate and cya-
nide (Fig. 5B). In the presence of 100M concentrations of both
thiocyanate and cyanide, about one-third of carbamylation
derived from thiocyanate and two-thirds from cyanide oxida-
tion (Fig. 5, B and C). Furthermore, higher concentration of
thiocyanate (400M) decreased the carbamylationmediated by
cyanide, but this was compensated by carbamylation mediated
by thiocyanate. Under these conditions, the production of
HOCl by MPO is lower than the production of HOSCN. How-
ever, the quantitative determination of Hcit demonstrated that
only 	0.4% of thiocyanate and cyanide were involved in Hcit
formation.Nevertheless, the carbamylation observed in LDLs is
about 6 times higher compared with the addition of cyanate
only (Fig. 5, A and B). Altogether, these data show a synergic
effect of thiocyanate, cyanide, and chloride in the carbamyla-
tion process. This synergy might reflect previous reports about
the reaction of cyanide with hypothiocyanate to a dicyanosul-
fide intermediate (36).
It remains to be discussed whether these reactions are rele-
vant in vivo. MPO and CN do exist in soluble forms in blood,
and the concentration ratios between these molecules used in
the above experiments match those reported in human blood
(e.g. [CN]/[MPO] ratio 	400:800, although the relative con-
centrations may vary depending on physiopathological condi-
tions (e.g. chronic or acute inflammation, diet, and smoking)
(38). Indeed, each cigarette can lead to exposure to 18–1500g
of cyanide (10). However, the concentration measured in
plasma even of smokers remains between 0.1 and 1.8 M (39).
But this can be explained by the rapid complexation and thio-
cyanate transformation (see also below). This led us to investi-
gate the impact of chronic exposure to cyanide in a mouse
model that expresses human MPO. The results of these exper-
iments demonstrate that the postulated pathways are relevant
in vivo. Protein-bound [13C,15N]homocitrulline was indeed
increased in hMPO-TG-LDLR/ mice that were exposed to
labeled cyanide. Of importance, this increase was observed in
atheroma plaque, where MPO and chronic inflammation are
present (27), but not in plasma or in the peritoneal lavages (cell
pellets and protein supernatant) during the acute inflammation
process. These results show that cyanide is involved in chronic
inflammatory processes by promoting the accumulation of pro-
tein-bound Hcit in atheroma plaque but is definitely not the
preferred pathway in acute processes.Moreover, the absence of
protein-bound [13C,15N]homocitrulline in plasma could reflect
a dilution effect, making this marker undetectable. Moreover,
cyanide oxidation byMPO in plasmamay be affected by natural
MPO inhibitors, such as the plasmametalloenzyme ceruloplas-
min, anti-MPO Igs, and components of the complement system
(40). Finally, it is important to highlight that the experiments
have been carried out based on a theoretical cyanide exposure
of 5 g/day for 8 weeks, which could lead to submicromolar
concentration of cyanide in blood. A better monitoring of cya-
nide exposure correlated to blood concentrations should help
in understanding the impact of cyanide exposure on cardiovas-
cular diseases.
On the other hand, cyanide is known to be rapidly metabo-
lized by three main routes (41): (i) production of 2-amino-4-
thiazoline carboxylic acid from cysteine andCN, (ii) synthesis
of cyanocobalamin (CN-B12) via binding to vitamin B12 ana-
logues (e.g. hydroxycobalamin or methylcobalamin), and (iii)
transformation into thiocyanate by a thiosulfate sulfurtrans-
ferase in the presence of a sulfur donor, such as thiosulfate (42).
All of these reactions hamper the quantification of MPO-me-
diated cyanide oxidation in vivo as well as of HOCl-mediated
cyanide oxidation. However, they have no impact on carbamy-
lation mediated by chloroamines and thiocyanate. The plasma
concentration of the latter is known to be modulated by diet
and smoking (7).
Summing up, this is the first work describing cyanide as a
substrate for a peroxidase, thereby changing the perception of
heme protein–cyanide interaction. The presented data also
suggest new pathways of cyanate formation and protein car-
bamylation in vivo that involve MPO either directly or its reac-
tion products hypochlorous acid and/or chloramines. The in
vivo experiments show that chronic exposure to cyanide pro-
motes the accumulation of carbamylated protein by multiple
chemical pathways in atheroma plaque in a mouse model that
mimics cardiovascular risk. Chronic exposure to air pollutants
produced by combustion of organic materials (e.g. industrial
and motor combustions) is reported to increase physiological
levels of cyanide (10, 43–45), and recent data confirm the link
between air pollution and cardiovascular risk (46–48). Future
studies should explore the impact of MPO on oxidation of cya-




Experiments were performed using both leukocyte and
recombinant MPO for which no differences in kinetics of tran-
sitions were observed within experimental errors (49). Highly
purified MPO of a purity index (A430/A280) of at least 0.85 was
purchased from Planta Natural Products. Transfection of
recombinant plasmids into Chinese hamster ovary cells, selec-
tion, culture procedures, and protein purification protocols
were described previously (50). The recombinant protein had a
purity index (A430/A280) of about 0.7. Generally, concentration
of MPO was calculated using 430 nm  91 mM1 cm1 as
described previously (51). Eosinophil peroxidase was purified
as described (52). Bovine lactoperoxidase and HRP were from
Sigma-Aldrich Handels GmbH (Vienna, Austria). Hydrogen
peroxide (H2O2) concentration was determined spectropho-
metrically at 240 nm ( 39.4 M1 cm1) (53).
LDLs were isolated from human plasma by ultracentrifuga-
tion according toHavel et al. (54). This study conformswith the
Declaration of Helsinki, and its protocol was approved by the
Ethics Committee of “CHU de Charleroi.” Finally, all subjects
gave their written informed consent. Before modification, the
LDL fraction (1.019 
 d 
 1.067 g/ml) was desalted by two
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consecutive passages through PD10 gel-filtration columns
(Amersham Biosciences) using phosphate buffer (10 mM, pH
7.4). The different steps were carried out in the dark, and the
protein concentration was measured by an ELISA kit for apoB-
100 measurement.
Amperometric analysis of hydrogen peroxide consumption
Hydrogen peroxide consumption by MPO was measured by
amperometry using a combined platinum/reference electrode
(covered with a hydrophilic membrane) fitted to an Ampero-
metric Biosensor Detector 3001 (Universal Sensors, Inc.). The
applied electrode potential at pH 7.4was 650mV, and theH2O2
electrode-filling solution was freshly prepared twice daily. The
electrode was calibrated against known concentrations of
H2O2. Consumption of H2O2 (100 M) in 100 mM phosphate
buffer, pH 7.4, was followed (25 °C), and reactions were started
by the addition of either 500 nM MPO, EPO, or LPO.
Transient-state experiments
Multimixing stopped-flow measurements were performed
with an SX-18MV spectrofluorometer (Applied Photophysics).
As soon as 100 l were shot into a flow cell having a 1-cm light
path, the fastest time for mixing the solution and recording the
first data point was 1.3 ms. The reactions were followed both at
fixed wavelength and by using a diode-array detector. At least
three determinations (2000 data points) of pseudo-first-order
rate constants (kobs) were performed for each substrate concen-
tration (pH 7.0, 25 °C). The mean value was used in the calcu-
lation of the second-order rate constants obtained from the
slope of the plot of kobs versus substrate concentration. Concen-
trations of substrates were at least 10 times in excess as com-
pared with that of the enzyme.
Due to the inherent instability of compound I of MPO, the
sequential stopped-flow (multimixing) technique was used for
determination of rates of reaction of compound I with cyanide.
Typically, MPO (8 M) was premixed with a 10-fold excess of
H2O2 in the aging loop for 30ms (100mMphosphate buffer, pH
7.0). LPO and HRP (8 M) were premixed with an equimolar
concentration of hydrogen peroxide for 100 and 1200 ms,
respectively. Finally, compound I was allowed to react with
varying concentrations of cyanide. Cyanide oxidation was fol-
lowed bymonitoring the absorbance change at 456 nm (MPO),
430 nm (LPO), and at 403 nm (HRP), respectively.
All reactions were also investigated using the diode-array
detector (Applied Photophysics PD.1) attached to the stopped-
flow machine. Normal data sets were analyzed using the Pro-K
simulation program fromApplied Photophysics, which allowed
the synthesis of artificial sets of time-dependent spectra as well
as spectral analysis of enzyme intermediates.
Carbamylation assays, product analysis, and Hcit quantitation
by MS
Cyanate productionwas carried out at 37 °C in a final volume
of 1.0 ml. The reaction mixture contained the following re-
agents at the final concentrations indicated in parentheses:
ammonium acetate buffer, pH 7.4 (10 mM), H2O2 (1 mM), and
cyanide (1 mM). The reaction was started by the addition of
MPO (300 nM). Alternatively, cyanate was obtained by mixing
isotopomers of cyanide (1 mM) and HOCl (1 mM) in the same
buffer. Cyanate concentration was calculated to a calibration
curve from 50 to 1000 M KOCN. After incubation for 1 h, the
solutionwas analyzed byMSusing an infusion systemwithin an
Agilent (Palo Alto, CA) 6520 ESI sourceQTOFmass spectrom-
eter in negative mode with a source temperature at 325 °C, a
VCap at 4500 V, a drying gas at 5 liters/min, a nebulizer gas at
10 p.s.i.g., a fragmentor at 150V, and a skimmer at 80V. Spectra
were accumulated for 2 min.
TandemMS/MS analysis of the cyanate production was car-
ried out by infusion on a Quattro premier XE (Waters, Milford,
MA) using an electrospray in negativemode with a source tem-
perature at 120 °C, a desolvation temperature at 400 °C, a gas
flow at 503 liters/h, a capillary voltage at 2.5 kV, and a cone
voltage at 50 V. The fragmentation was allowed with collision
energy at 90 eV. The spectra are the results of 30 accumulated
scans.
Reactions of carbamylation were performed in triplicate in
10 mM ammonium acetate buffer, pH 7.4, at 37 °C with recom-
binant MPO. Usually a 50:50 methanol/solution mixture was
directly infused (0.3 ml/min) into the Agilent QTOF described
above, and spectra were accumulated for 2 min.
Carbamylation of taurine or lysine was performed using a
mixture of taurine (1 mM) or lysine (1 mM), MPO (300 nM), and
cyanide (1 mM) in ammonium acetate buffer, pH 7.4 (37 °C),
and the reaction was started by the addition of H2O2 (1 mM).
Chlorotaurine was produced by mixing taurine (1 mM) with
HOCl (500 M) at 37 °C. After 4 h, cyanide (1 mM) or thiocya-
nate (1 mM) was added. After 12 h, carbamyltaurine and
homocitrulline formation was analyzed in negative mode on
the ESI-QTOF described above with a source temperature at
325 °C, a VCap at 4000 V, a drying gas at 5 liters/min, a nebu-
lizer gas at 10 p.s.i.g., a fragmentor at 165V, and a skimmer at 80
V. MS/MS spectra were obtained by monitoring the collision
energy at 1 V. Analysis of carbamyllysine was performed with
the same specifications but in positive mode. Standard solu-
tions were obtained by mixing in taurine (1 mM) or lysine (1
mM) with cyanate (1 mM) at 37 °C under identical conditions
(incubation time of 12 h).
LDLs (1 mg/ml) were isolated by standard protocol (54) and
were incubated overnight in phosphate buffer (10 mM), pH 7.4
(37 °C), with MPO (300 nM) and cyanide (10, 100, or 1000 M)
with or without chloride (150mM). The reaction was started by
the addition ofH2O2 (1mM). A control conditionwithoutMPO
but with H2O2 (1 mM) and cyanide (100 M) was also per-
formed. LDLs (1 mg/ml) were also incubated with phosphate
buffer (10mM), pH 7.4 (37 °C), and cyanide (100 M) before the
addition of HOCl (1 mM). A positive control where LDLs (1
mg/ml) were incubated overnight in the same buffer in the
presence of cyanate (100 M) at 37 °C was performed. LDLs (1
mg/ml) were also incubated for 4 h (37 °C)withHOCl (1mM) in
phosphate buffer (10 mM), pH 7.4 (37 °C), before the addition
of thiocyanate (100 M) and overnight incubation. Finally,
LDLs (1mg/ml) were incubated overnight (37 °C) in phosphate
buffer (10 mM), pH 7.4 (37 °C), with MPO (300 nM), chloride
anions (150 mM), thiocyanate (100 or 400 M), and [13C,15N]
cyanide (10 or 100 M).
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Native LDL and carbamyl-LDL were precipitated with TCA
(10%) and centrifuged for 10 min at 16,000  g. Supernatant
was discarded, and the process was repeated one more time.
The precipitate was then mixed with a solution of water/meth-
anol/diethylic ether (1:3:7) to remove lipids. The mixture was
centrifuged 10 min at 16,000  g, the supernatant was dis-
carded, and the process was repeated. The obtained pellets
were dried down using a vacuum centrifuge before acid hydro-
lysis, derivatization, andMS/MSanalysis. The latterwas carried
out as described below.
Carbamylationwasmonitored byLC-MS/MSafter acidic hy-
drolysis as described previously (55). [13C,15N]Lysine (3.4 M,
final concentration) was added as an internal standard. Acid
hydrolysis was carried out at 110 °C using a microwave oven;
resulting amino acid residues were labeled, and samples were
cleaned up as described previously (55). At the end of the pro-
cess, samples were reconstituted in 0.1% formic acid and
injected into a 1290 Infinity series UHPLC system (Agilent
Technologies, Palo Alto, CA). Amino acid residues were
resolved on a Poroshell 120 EC-C18 column (2.1 100mm, 2.7
m) (Agilent Technologies) using a gradient of 0.2% formic
acid and methanol. Lys, Hcit, and [13C,15N]Hcit residues were
quantified by tandem MS on a 6490 series ESI-triple quadru-
pole mass spectrometer using a JetStream source (Agilent
Technologies, Palo Alto, CA). Parameters were as follows: pos-
itive mode; dynamic MRM; gas temperature of 250 °C; drying
gas of 14 liters/min; nebulizer pressure of 20 p.s.i.g.; sheath gas
heater at 350 °C; sheath gas flow of 7 liters/min; capillary volt-
age of 3000 V; high-pressure RF of 150 V; low pressure RF of 60
V; fragmentor at 380 V. Fixed collision energies (CEs) were
optimized for each residue and for each product ion andwere as
follows: Hcit, precursor ion m/z of 246.2, quantifier product
ion 229.1 using CE 9 V, qualifier product ion 84.1 using
CE  25 V; [13C,15N]Hcit: precursor ion m/z of 248.2, quanti-
fier product ion 230.1 usingCE 9V, qualifier product ion
84.1 using CE 25 V; Lys: precursor ion m/z of 203.2, quanti-
fier product ion 186.2 usingCE 9V, qualifier product ion
84.1 using CE  13 V. The precursor ions correspond to the
butanolic esters of the amino acid residues. Precursor isolation
modewas in unitmode for Lys and enhancedmode forHcit and
[13C,15N]Hcit. For the quantitation of Hcit in samples, a stan-
dard curve of Hcit was performed from 1 to 10,000 nM, and
[13C,15N]lysine was used as an internal standard. Data were
acquired using MassHunter Acquisition software and ana-
lyzed by MassHunter Quantitative Analysis software (version
B.07, Agilent Technologies).
Animals
Age- and sex-matched C57BL/6, humanMPO transgenics
(463G allele) (hMPO-TG), and hMPO-TG crossed to the
LDLR/ mice on the C57BL/6 background were used in
these studies. All animal experiments adhered to the Guide
for the Care and Use of Laboratory Animals (56) and were
performed using approved protocols from the Animal
Research Committee at Sanford Burnham Prebys Medical
Discovery Institute.
Potassium cyanide exposure of mice
Mice were fed a high-fat atherogenic diet (42% kcal from fat)
(Envigo, TD 88137) for 12 weeks. After 4 weeks on a high-fat
diet, the mice were randomly allocated to treated or control
groups. Mice in the first group were injected intraperitoneally
with potassium [13C,15N]cyanide (0.4 mg/kg, 	5 g/day) in
PBS every day for 8 weeks. Control mice were injected with
PBS. Blood collection at sacrifice was by cardiac puncture
under Avertin anesthetic. Serum was prepared by centrifuga-
tion and stored at 80 °C until analyzed. The mice were then
perfused with ice-cold PBS through the left ventricle, and prox-
imal aortae were carefully dissected to remove adventitial fat.
The region of the aorta containing the plaque was removed and
frozen at 80 °C until analyzed. The brain, liver, and kidney
were also collected and stored at80 °C until analyzed.
Mouse model of inflammation
The procedure for inflammation was performed essentially
as described by Wang et al. (7) except that in this study, we
injected potassium [13C,15N]cyanide. Briefly, animals were
injected intraperitoneally with 1 ml of 4% thioglycollate broth.
Twenty hours later, mice were injected with zymosan (250
mg/kg) andpotassium [13C,15N]cyanide (1.6mg/kg). Peritoneal
lavage was performed 4 h later with PBS containing 100 M
butylated hydroxytoluene and 100 M diethylenetriaminepen-
taacetic acid. The samples were centrifuged at 1000 rpm for 5
min at 4 °C to separate the lavage fluid from the peritoneal cells.
The samples were frozen and stored at80 °C until analyzed.
Statistics
Data were analyzed using SigmaPlot version 12.0 software.
Mean values with S.D. were reported because the data were
normally distributed (normality tests, Shapiro-Wilk passed).
Parametric t tests were the most appropriate for our study
design. Outcomes were considered as statistically significant
with a two-tailed p 
 0.05. Based on six preliminary mice
(treated versus nontreated, difference on mean and S.D.), we
determined the number ofmice to obtain a power of performed
two-tailed test (with  0,050) to 0.8. No mice were excluded
from the study.
The operator was blinded, as each sample was allocated to a
code number, and the corresponding group was revealed after
LC-MS data analyses and before statistical analysis.
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Moguilevsky, N., Nève, J., Vanhamme, L., Van Antwerpen, P., and
Zouaoui Boudjeltia, K. (2012) Simultaneous measurement of protein-
bound 3-chlorotyrosine and homocitrulline by LC-MS/MS after hydroly-
sis assisted by microwave: application to the study of myeloperoxidase
activity during hemodialysis. Talanta 99, 603–609 CrossRef Medline
56. National Research Council of the National Academies (2011) Guide for
the Care and Use of Laboratory Animals, 8th Ed., National Academies
Press, Washington, D. C.
MPO oxidizes cyanide into cyanate
6386 J. Biol. Chem. (2018) 293(17) 6374–6386
